Company news
Ryvu Therapeutics Sa (GPW:RVU) news
Ryvu Therapeutics Sa news releases on 6ix. Latest, May 16, 2024: Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
Press releases & updates
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
May 16, 2024
Ryvu Therapeutics - Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes
October 23, 2023
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Solid Tumors and AML/HR-MDS, and Presents the Updated Development Plan for RVU120
October 23, 2023
Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds Over PLN 250 Million
December 22, 2022
Ryvu Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 24, 2022
Ryvu Therapeutics Announces Poster Presentations at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Symposium
October 12, 2022
Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board
July 26, 2022